A detailed history of Ewa, LLC transactions in Compugen LTD stock. As of the latest transaction made, Ewa, LLC holds 66,548 shares of CGEN stock, worth $109,138. This represents 0.05% of its overall portfolio holdings.

Number of Shares
66,548
Previous 67,737 1.76%
Holding current value
$109,138
Previous $136 Million 9.58%
% of portfolio
0.05%
Previous 0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$1.68 - $2.52 $1,997 - $2,996
-1,189 Reduced 1.76%
66,548 $123 Million
Q1 2024

May 13, 2024

SELL
$1.75 - $2.95 $2,290 - $3,861
-1,309 Reduced 1.9%
67,737 $136 Million
Q4 2023

Feb 05, 2024

SELL
$0.53 - $2.0 $1,605 - $6,060
-3,030 Reduced 4.2%
69,046 $157 Million
Q3 2023

Nov 14, 2023

BUY
$0.88 - $1.31 $46,425 - $69,110
52,756 Added 273.06%
72,076 $38.2 Million
Q2 2023

Aug 10, 2023

BUY
$0.57 - $1.38 $1,294 - $3,133
2,271 Added 13.32%
19,320 $22 Million
Q1 2023

May 15, 2023

BUY
$0.68 - $1.11 $11,593 - $18,924
17,049 New
17,049 $12.6 Million

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $142M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Ewa, LLC Portfolio

Follow Ewa, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ewa, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ewa, LLC with notifications on news.